HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuichi Sakamori Selected Research

Microtubule-Associated Proteins (Microtubule-Associated Protein 2)

1/2013Disease flare after discontinuation of crizotinib in anaplastic lymphoma kinase-positive lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuichi Sakamori Research Topics

Disease

46Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2024 - 01/2010
21Neoplasms (Cancer)
04/2024 - 07/2010
12Lung Neoplasms (Lung Cancer)
08/2023 - 03/2010
9Neoplasm Metastasis (Metastasis)
07/2022 - 03/2010
6Small Cell Lung Carcinoma (Small Cell Lung Cancer)
07/2022 - 05/2010
6Adenocarcinoma of Lung
09/2017 - 02/2011
3Disease Progression
05/2020 - 01/2013
3Brain Neoplasms (Brain Tumor)
09/2013 - 04/2010
2Malignant Mesothelioma
11/2022 - 07/2012
2Interstitial Lung Diseases (Interstitial Lung Disease)
10/2017 - 08/2012
2Pleural Effusion (Pleural Effusions)
09/2011 - 09/2010
2Chronic Kidney Failure (Chronic Renal Failure)
04/2011 - 05/2010
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2021
1Carcinogenesis
09/2017
1Hepatitis
08/2017
1Neutropenia
05/2016
1Thymoma (Thymic Carcinoma)
05/2016
1Intracranial Hemorrhages (Intracranial Hemorrhage)
09/2013
1Pain (Aches)
03/2013
1Dyspnea (Shortness of Breath)
03/2013
1Lymphoma (Lymphomas)
01/2013
1Pneumonia (Pneumonitis)
07/2012
1Lewis Lung Carcinoma
07/2012
1Diarrhea
10/2011
1Nausea
10/2011
1Anorexia
10/2011
1Hemorrhage
10/2011
1Stomatitis
10/2011

Drug/Important Bio-Agent (IBA)

14ErbB Receptors (EGF Receptor)IBA
01/2017 - 01/2010
11Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2013 - 04/2010
8Gefitinib (Iressa)FDA Link
09/2012 - 01/2010
7NivolumabIBA
08/2023 - 01/2017
6Tyrosine Kinase InhibitorsIBA
02/2023 - 05/2010
6Pemetrexed (MTA)FDA Link
05/2020 - 03/2011
6Anaplastic Lymphoma KinaseIBA
01/2020 - 01/2013
4Bevacizumab (Avastin)FDA Link
05/2020 - 05/2011
4alectinibIBA
01/2020 - 11/2018
4CrizotinibIBA
01/2019 - 01/2013
3Immune Checkpoint InhibitorsIBA
04/2024 - 08/2023
3Biomarkers (Surrogate Marker)IBA
01/2020 - 10/2011
3Paclitaxel (Taxol)FDA LinkGeneric
10/2017 - 01/2015
3Albumin-Bound PaclitaxelFDA Link
10/2017 - 05/2016
3SolventsIBA
10/2017 - 01/2015
3Epidermal Growth Factor (EGF)IBA
09/2012 - 04/2010
3OSI-420IBA
09/2011 - 05/2010
2Proteins (Proteins, Gene)FDA Link
02/2023 - 01/2020
2LigandsIBA
12/2022 - 01/2020
2Carboplatin (JM8)FDA LinkGeneric
05/2020 - 05/2016
2amrubicinIBA
03/2020 - 05/2010
2AlbuminsIBA
10/2017 - 07/2016
2130-nm albumin-bound paclitaxelIBA
10/2017 - 07/2016
2Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
09/2017 - 09/2012
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2013 - 08/2011
2Phosphotransferases (Kinase)IBA
01/2013 - 04/2010
2Insulin-Like Growth Factor Binding Protein 3IBA
09/2012 - 10/2011
2Insulin-Like PeptidesIBA
09/2012 - 10/2011
1Immunologic Factors (Immunomodulators)IBA
04/2024
1Immune Checkpoint ProteinsIBA
04/2024
1Therapeutic UsesIBA
02/2023
1Verteporfin (Visudyne)FDA Link
02/2023
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
02/2023
1lorlatinibIBA
02/2023
1BezafibrateIBA
12/2022
1Peptides (Polypeptides)IBA
07/2022
1big gastrinIBA
07/2022
1S63845IBA
01/2020
1navitoclaxIBA
01/2020
1Apoptosis Regulatory ProteinsIBA
01/2020
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2020
1saracatinibIBA
01/2019
1src-Family KinasesIBA
01/2019
1ceritinibIBA
11/2018
1locked nucleic acidIBA
01/2017
1Peptide Nucleic AcidsIBA
01/2017
1Circulating Tumor DNAIBA
01/2017
1Monoclonal AntibodiesIBA
09/2013
1Vinorelbine (Navelbine)FDA LinkGeneric
06/2013
1PlatinumIBA
06/2013
1Docetaxel (Taxotere)FDA Link
06/2013
1Morphine (MS Contin)FDA LinkGeneric
03/2013
1Formaldehyde (Formol)FDA Link
02/2013
1ParaffinIBA
02/2013
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2013
1NOC 18IBA
07/2012
1Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2012
1Folic Acid AntagonistsIBA
07/2012
1Antineoplastic Agents (Antineoplastics)IBA
07/2012
1Nitroglycerin (Dynamite)FDA LinkGeneric
07/2012

Therapy/Procedure

15Therapeutics
04/2024 - 01/2010
14Drug Therapy (Chemotherapy)
12/2021 - 09/2010
2Immunotherapy
12/2022 - 01/2020
2Aftercare (After-Treatment)
01/2020 - 09/2017
2Renal Dialysis (Hemodialysis)
04/2011 - 05/2010
1Cranial Irradiation
07/2022
1Chemoradiotherapy
03/2020
1Drug Tapering
05/2016
1Radiotherapy
09/2013
1Oral Medicine
03/2013
1Adjuvant Chemotherapy
01/2013
1Retreatment
08/2012